Objective: To evaluate the potential impact of molecular phenotyping of transbronchial biopsies in lung transplant recipients with allograft dysfunction, and the potential for developing a safer endobronchial mucosal biopsy format.
Lung Transplant Rejection
Objective: To evaluate the potential impact of molecular phenotyping of transbronchial biopsies in lung transplant recipients with allograft dysfunction, and the potential for developing a safer endobronchial mucosal biopsy format.
Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation
-
University of Maryland School of Medicine, Baltimore, Maryland, United States, 21201
Division of Pulmonary and Critical Care, Washington University School of Medicine, Saint Louis, Missouri, United States, 63110
University of Texas at San Antonio, San Antonio, Texas, United States, 21201
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
University of Alberta,
Philip F Halloran, MD, PhD, PRINCIPAL_INVESTIGATOR, Faculty of Medicine and Dentistry, University of Alberta
2026-06